Unlike the human genome, which is relatively consistent across populations, the gut microbiome is shaped by diet, culture, and geography. In Singapore, a research team is racing to rewrite the microbiome rulebook, recognizing that precision medicine needs localized data to be truly effective. Using QIAGEN’s EZ2 PowerFecal Pro DNA/RNA kit, the team is laying the groundwork for region-specific data that challenge the one-size-fits-all approach to microbiome science.
EZ2 PowerFecal Pro DNA/RNA Kit
For the automated isolation of microbial DNA, RNA or total nucleic acids from stool samples using the EZ2 Connect Why gut health needs local data
Diet, culture, and geography shape our gut. So why use global norms? Dr. Jeremy Lim and Haikel Rasiti explain why building Asia’s own microbiome biobank is essential for better diagnostics, treatments, and health outcomes.
“It’s very clear that the microbiome is going to have a major impact in medicine and how we understand human health”
Dr. Jeremy Lim, CEO and Co-Founder, AMILI
Diseases impacted by the microbiome
Gut microbiota imbalances have been directly linked to several diseases, many of which AMILI is actively addressing through microbiome profiling, clinical research, and fecal microbiota transplantation (FMT):
Bios
Dr. Jeremy Lim, CEO and Co-Founder, AMILI
Dr. Jeremy Lim is the CEO and Co-Founder of AMILI, Southeast Asia’s leading precision gut microbiome company. A medical doctor with dual training in surgery and public health, he has held leadership roles across public and private healthcare, including as Partner at Oliver Wyman and Director at NUS’s School of Public Health. A Fulbright Scholar and published author, he actively advises global health organizations and contributes to public policy and digital health innovation in Asia.
Haikel Rasiti, Lead, Laboratory Operations, AMILI
Haikel Rasiti is Lead of Laboratory Operations at AMILI, where he oversees microbiome sample processing and biobank development. He plays a key role in scaling laboratory workflows to support AMILI’s mission of building Southeast Asia’s largest multiethnic gut microbiome database and advancing region-specific health research.
References:
1. Liubakka A, et. al. Clostridium difficile Infection and Fecal Microbiota Transplant. AACN Adv Crit Care. 2016 Jul;27(3):324-337.
June 2025